20 March 2026. The TIGERS-X (Thailand Innovative G-force varied Emulsification Research for Space Exploration) experiment cube, developed by the Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, has officially delivered the payload to Space Applications Services in Zaventem, Belgium, in preparation for its upcoming mission to the International Space Station (ISS) aboard SpaceX CRS-34.
The TIGERS-X experiment cube is a demonstration of Thailand’s space technology applied to the medical industry. The core objective of the mission is to study the emulsification behavior of Total Parenteral Nutrition (TPN), or intravenous nutritional fluids, in a microgravity environment. On Earth, gravity typically causes oil-and-water mixtures to separate rapidly. However, the microgravity allows scientists to observe mixing behaviors that differ significantly from those on the ground. The experiment uses a Microfluidic Static Mixer system, which enables fluid mixing without the need for mechanical moving parts. This innovation could lead to the development of highly efficient drug and nutrient production technologies for patients in the future.
During the delivery process, Space Applications Services conducted final verification procedures, focusing on safety and compatibility with ISS systems. TIGERS-X successfully passed all testing phases and is now cleared for integration as cargo on the SpaceX Cargo Dragon 2 for the CRS-34 (SpX-34) mission. The launch is scheduled for May 12, 2026, via a Falcon 9 rocket from Launch Complex 39A (LC-39A) at NASA’s Kennedy Space Center in Florida, USA.
Upon completion of the mission, the TIGERS-X payload will return to Earth aboard the Dragon spacecraft, allowing the research team to analyze the results. This mission not only proves Thailand’s end-to-end engineering capabilities but also serves as a strategic milestone in establishing Thailand’s presence within the New Space Economy.
